Vladislav Sandler is the founder of HemoGenyx. HemoGenyx has raised $1M in total funding. Latest round: Seed. Backed by Vladislav Sandler.
Vladislav Sandler is the Co-Founder and Chief Executive Officer of Hemogenyx Pharmaceuticals plc, a clinical-stage biotechnology company focused on blood cancer therapies. He leads the company's development of CAR-T therapy and a CD19-specific antibody candidate. Sandler has personally invested in the company to fund clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library